Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: (TSXV:
$META.V) (CSE: $EURO.C) (CSE: $HUGE.C) (CSE: $CURA.C) (CSE: $TIUM.C)
Delta, Kelowna, BC –August 21, 2019 (Investorideas.com
Newswire) www.Investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and
experts.
Listen to the podcast:
Good afternoon and welcome to another episode of
Investorideas.com "Potcast" featuring cannabis news, stocks to watch
as well as insights from thought leaders and experts.
In
today’s podcast we look at a few early announcements.
But
first, in recent news, the federal government has become overwhelmed
with the large amount of cannabis research applications that have been steadily
coming in since last October.
As
of last month, there were 251 applicants waiting in the queue for approval, and
scientists are becoming increasingly irritated with the stagnancy of the
process, which is currently subject to waits lasting months at a time.
“It’s
incredibly slow—much slower than it used to be,” University of Lethbridge plant
geneticist Igor Kovalchuk, told Science magazine. “October 17, 2018, is when
things slowed down tremendously.”
Federal
legalization produced an instant flood of cannabis research applications for
Health Canada which they are attempting to manage on top of those applications
for cultivation, processing, retail and other aspects of the strictly-regulated
industry that require the federal agency’s approval.
Health
Minister Ginette Petitpas-Taylor announced
in May that it is investing in its own research projects relating to the drug.
“We
are investing in research to provide the evidence needed to maintain policies
for cannabis use that protect the health and safety of Canadians,” she said.
National Access Cannabis Corp. (TSXV:
META), Canada's largest cannabis retailer1,
today
provided investors with a corporate and retail
sales update. The Company is successfully executing on its growth strategy and
has achieved over $50 million in retail sales since legalization, with
cumulative gross margin in excess of 31%. The Company is targeting to have 40
operating stores by the end of calendar 2019.
"NAC is rapidly growing its store
count and revenue," said Mark Goliger, CEO of NAC. "We have been
granted 10 licenses in Alberta since the ending of the moratorium on May 31st,
and we expect positive movement with our licence applications in British
Columbia. We now have 30 stores open, with another 5 stores licensed and in
development. We expect continued revenue
momentum as we roll out improved and streamlined store designs to enhance
customer experience. With the recent filing of our final base shelf prospectus
to provide us with flexible access to capital, we are confident in our ability
to execute on our strategic growth initiatives to continue our leadership
position in Canadian cannabis retail."
The Company's current portfolio of 35
licensed locations is split as follows:
●
25 NewLeaf Cannabis™ stores in Alberta
●
9 Meta Cannabis Supply Co.™ stores in
Manitoba
●
1 Meta Cannabis Supply Co.™ store in
Saskatchewan
FSD Pharma Inc. (CSE:
HUGE) (OTCQB:
FSDDF) today
announced the launch of its online ordering system
for the direct fulfillment of medicinal cannabis orders. Through its
wholly-owned subsidiary, FV Pharma Inc., clients with a prescription from a
medical practitioner or a registration number with Health Canada can now place
an order online for dried cannabis on FVPharma.com.
"The launch of a functional online
ordering portal to fulfill prescriptions for medicinal cannabis is a very
important milestone for FSD Pharma. Since receipt of our Sale for Medical
Purposes license earlier in June, we are now open for registration online to a
wider client base and we are pleased that patients have already begun to use
our user friendly website," said Raza Bokhari, MD, FSD Executive
Co-Chairman & Chief Executive Officer.
"I want to personally congratulate
the FSD Pharma team in helping the company advance into this important phase;
we still have many more successful chapters to write together," concluded
Dr. Bokhari.
EuroLife Brands Inc. (CSE:
EURO) (OTCPK: CANVF), a leading global
markets cannabis brand empowering the medical, recreational and CPG cannabis
industry worldwide, announced that
its corporate rebranding and repositioning within the cannabis industry has
been completed with the launch of its EuroLifeBrands.com company website and
corporate refocus.
"With our corporate rebrand
complete, we are free to focus all efforts on continuing to grow the EuroLife
cannabis brand across Europe and South America with a determination on new
opportunities, strategic mergers and acquisitions to build shareholder
value," said Shawn Moniz, Chief Executive Officer, EuroLife Brands Inc.
"We expect to quickly become a leader in the burgeoning CPG CBD market
across Europe by leveraging our rich repository of unbiased and
physician-backed original educational content alongside our in-depth consumer
data and analytics."
Demonstrating the Company's commitment to
providing accessible cannabis education, its Director of Strategy and Education
Daniel Davidzon was recently published in the National Post arguing for the
crucial need for evidence-based cannabis education for cannabis consumers
across Canada and the world. With so many cannabis-curious consumers confused
over what treatments, products and services available to them, the need for an
education-driven marketplace has grown exponentially and EuroLife is poised to
lead the market with its repository of over 400 physician-backed and
educator-approved articles and over 70 courses in its education platform.
The EuroLife executive team devoted a
significant amount of time over the last quarter quantifying strategic partners
across Europe in both the cannabis sector and other industries to determine the
organization's realignment and strengthen the brand's presence across the
continent. A recent report from the Brightfield Group, a leading market
intelligence firm for the legal CBD and cannabis industries, estimated the
European CBD market at USD $318 million in 2018, with the expectation of
booming growth over 400 percent through 2023. The global CBD market is
projected to grow from USD $1 billion in 2018 to USD $16 billion by 2026,
according to Fior Market Research, a futuristic market intelligence company.
While the Company shifts its European and
South American activities toward the CBD market, the anchor of its North
American operations remains its Canadian and U.S.-focused digital cannabis
education resource Cannvas.Me and Cannvas.Pet.
Eurolife is also announced the formation
of a new Veterinary Advisory Board to guide educational content for its
Canvas.Pet platform, as well as two new culinary-focused appointments to its
Cannabis Sciences Advisory Board.
Award-winning veterinarian Dr. Scott
Bainbridge has been appointed as the Veterinary Advisory Board lead, bringing
with him nearly 20 years of veterinary expertise across a range of practices.
Dr. Bainbridge and his team of eight vets diagnose approximately 15,000 cases
every year at his Dundas West Animal Hospital (DWAH) in Toronto. Recently
honoured by the Ontario Veterinary Medical Association with a lifetime
achievement for public service, Dr. Bainbridge makes regular appearances on
radio and television, appearing on CP24's Animal House Calls as a regular
contributor and acts as the expert veterinarian for Canadian Living Magazine.
Award-winning author and culinary
herbalist Pat Crocker, and founder of Upward Cannabis Kitchen, Carlton Bone,
join the Cannabis Sciences Advisory Board to provide insights into
evidence-based education around cannabis-infused edibles and beverages while
contributing potential consumer packaged goods offerings to the EuroLife
Marketplace platform.
A prolific author and in-demand speaker,
Pat Crocker has written over 22 cookbooks. Her latest project is Healing
Cannabis Edibles, a revolutionary cookbook and healing guide encouraging
informed decisions around cannabis consumption to potentially improve certain
health conditions. Ms. Crocker's books have sold hundreds of thousands of
copies and have been featured on bestseller's lists across North America,
including The Globe and Mail.
The founder of Portland, Oregon-based
Upward Cannabis Kitchen, Carlton Bone has a passion for crafting high quality
cannabis products and has developed a tea-based cannabis beverage line. Carlton
also acts as the Chief Information Officer for Dr. Melanie Bone, a physician
and educator with a focus on the intersection of cannabis and women's health
care. Recently, the two collaborated on creating cannabis-infused suppositories
to support anyone who needs relief due to chronic pain or additional comfort
during their cycle.
Cansortium
Inc. (CSE:
TIUM-U) (OTCQB:
CNTMF), a vertically-integrated, global
provider of premium-quality medical cannabis operating under the Fluent™ brand,
announced
today that it will begin trading today on the
OTCQB Venture Market under the ticker "CNTMF". This is an upgrade from the Company's
previous classification on the Pink Open Market.
Cansortium Chief Executive Officer Jose
Hidalgo emphasized, "We are very pleased to begin trading on the OTCQB
Venture Market less than five months after our initial public offering on the
Canadian Securities Exchange, adding valuable visibility and additional liquidity
for the benefit of our shareholders. We are intently focused on executing our
growth strategy by expanding our cultivation capacity and dispensary platform
in our home state of Florida and establishing our Fluent™ brand of cannabis
products as a leader in each market where we choose to compete."
Curaleaf Holdings, Inc. (CSE:
CURA) (OTCQX: CURLF), a
leading vertically integrated cannabis operator in the United States, today
announced it has obtained eligibility with The
Depository Trust Company ("DTC") for its shares listed on the OTCQX.
DTC is a subsidiary of the Depository Trust & Clearing Corporation, a U.S.
company that manages the electronic clearing and settlement of publicly traded
companies. DTC eligibility provides cost benefits for investors and brokers
trading in our securities in the United States.
"Receiving DTC eligibility will
allow for a more friendly trading experience for our current and future
shareholders," said Joseph Lusardi, CEO of Curaleaf. "Shareholders of
Curaleaf will now be able to electronically transfer shares between brokerages
in the U.S. and with this improved access to our shares, we expect a positive
impact to the liquidity and demand for our stock."
Investor ideas reminds all listeners to read our disclaimers and
disclosures on the
Investorideas.com website and this podcast is not an endorsement
to buy products or services or securities. Investors are reminded all
investment involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also
available on iTunes, Spotify, Google
Play Music, Stitcher, Spreaker, YouTube
via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark
on the blockchain through Cognate, Inc. CM Certification-Registration Number:
10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news
source publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play
by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News
and Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the AI
Eye Podcast and column covering developments in
AI.
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and followers.
Contact management and IR of each company directly regarding specific
questions.
Investor Ideas does not condone the use of cannabis except where permissible
by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
